Jean Louis Vildé
Research Subjects
Jean Louis Vildé has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Guillaume Breton
Department of Infectious and Tropical Diseases, Bichat Claude Bernard Hospital, Paris, France
2 shared publicationsAmélie Carbonnelle
1 shared publicationBernard Régnier
1 shared publicationCatherine Leport
Pharmacology, Bichat Claude Bernard Hospital, Paris
1 shared publication- Catherine Leport
Université Paris-Diderot, Inserm 1137, UMR 1137, 16, rue Henri-Huchard, 75870, Paris, Cedex 18, France
1 shared publication Didier Trophilme
1 shared publication
Latest Publications
- 8 July 2004
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 36 (6-7) , 527-528
Tubulopathy Consecutive to Tenofovir-containing Antiretroviral Therapy in Two Patients Infected with Human Immunodeficiency Virus-1
Tenofovir disopril fumarate, a new nucleotide analogue against human immunodeficiency virus-1 (HIV-1), can induce hypophosphataemia, the mechanism of which is unclear. Moreover, a renal tubulopathy can occur in long-term treated patients, as observed in 2 HIV-1-infected patients after 12 months of tenofovir therapy, with polyuria–polydipsia, proteinuria, glycosuria and amino-aciduria, which resolved after discontinuation of tenofovir. The risk of renal tubulopathy symptoms in patients on long-term tenofovir therapy should be noted.
- 8 July 2004
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 36 (6-7) , 527-528
Tubulopathy Consecutive to Tenofovir-containing Antiretroviral Therapy in Two Patients Infected with Human Immunodeficiency Virus-1
Tenofovir disopril fumarate, a new nucleotide analogue against human immunodeficiency virus-1 (HIV-1), can induce hypophosphataemia, the mechanism of which is unclear. Moreover, a renal tubulopathy can occur in long-term treated patients, as observed in 2 HIV-1-infected patients after 12 months of tenofovir therapy, with polyuria–polydipsia, proteinuria, glycosuria and amino-aciduria, which resolved after discontinuation of tenofovir. The risk of renal tubulopathy symptoms in patients on long-term tenofovir therapy should be noted.
- 1 April 2004
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 34 (4) , 180
Revue subjective de la littérature : adéfovir–dipivoxil
- 1 April 2004
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 34 (4) , 180
Revue subjective de la littérature : adéfovir–dipivoxil
- 1 June 2003
- Vol. 23 (3) , 216-35
[Non tuberculous mycobacterial diseases].
Mycobacteria species other than members of Mycobacterium tuberculosis complex are called non tuberculous mycobacteria (NTM) or "atypical" mycobacteria. To date, about 80 mycobacterial species have been described. They are usually opportunistic pathogens with variable degrees of virulence. Tuberculosis is the commonest mycobacterial disease in the world, followed by leprosy and Buruli ulcer. Before the AIDS epidemic, NTM diseases were confined to the lungs (M. kansasii, M. intracellulare and M. avium), the skin (M. marinum) or cervical lymph nodes (M. scrofulaceum). The outbreak of AIDS epidemic has dramatically changed the epidemiology of NTM diseases. Between 25 to 50% of AIDS patients in Europe and USA are infected with NTM. NTM infections are usually disseminated in patients with profound immunodeficiency. The inflammatory response and the prognosis of NTM diseases depend on the immunological status and the NTM species. Diagnosis may be difficult, especially in AIDS patients in whom numerous diseases are often associated. Diagnostic criteria involve clinical, radiological, microbiological and pathological findings. Identification of Mycobacterium species in cultures is the gold standard. Pathological examination has several interests: it may reveal an NTM disease, it provides a more rapid assessment of the infection than cultures, and helps to evaluate the virulence of NTM species identified by cultures.
- 1 June 2003
- Vol. 23 (3) , 216-35
[Non tuberculous mycobacterial diseases].
Mycobacteria species other than members of Mycobacterium tuberculosis complex are called non tuberculous mycobacteria (NTM) or "atypical" mycobacteria. To date, about 80 mycobacterial species have been described. They are usually opportunistic pathogens with variable degrees of virulence. Tuberculosis is the commonest mycobacterial disease in the world, followed by leprosy and Buruli ulcer. Before the AIDS epidemic, NTM diseases were confined to the lungs (M. kansasii, M. intracellulare and M. avium), the skin (M. marinum) or cervical lymph nodes (M. scrofulaceum). The outbreak of AIDS epidemic has dramatically changed the epidemiology of NTM diseases. Between 25 to 50% of AIDS patients in Europe and USA are infected with NTM. NTM infections are usually disseminated in patients with profound immunodeficiency. The inflammatory response and the prognosis of NTM diseases depend on the immunological status and the NTM species. Diagnosis may be difficult, especially in AIDS patients in whom numerous diseases are often associated. Diagnostic criteria involve clinical, radiological, microbiological and pathological findings. Identification of Mycobacterium species in cultures is the gold standard. Pathological examination has several interests: it may reveal an NTM disease, it provides a more rapid assessment of the infection than cultures, and helps to evaluate the virulence of NTM species identified by cultures.
- Open Access
- 1 May 1999
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 28 (5) , 1180-1181
Two Episodes of Acute Renal Failure, Rhabdomyolysis, and Severe Hepatitis in an AIDS Patient Successively Treated with Ritonavir and Indinavir
Olivier Benveniste, Pascale Longuet, Xavier Duval, Vincent Le Moing, Catherine Leport, Jean Louis Vilde; Two Episodes of Acute Renal Failure, Rhabdomyolysis, a
- 1 May 1999
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 28 (5) , 1180-1181
Open AccessTwo Episodes of Acute Renal Failure, Rhabdomyolysis, and Severe Hepatitis in an AIDS Patient Successively Treated with Ritonavir and Indinavir
Olivier Benveniste, Pascale Longuet, Xavier Duval, Vincent Le Moing, Catherine Leport, Jean Louis Vilde; Two Episodes of Acute Renal Failure, Rhabdomyolysis, a